» Articles » PMID: 9371338

Characterization of Fluoroquinolone-induced Achilles Tendon Toxicity in Rats: Comparison of Toxicities of 10 Fluoroquinolones and Effects of Anti-inflammatory Compounds

Overview
Specialty Pharmacology
Date 1997 Nov 26
PMID 9371338
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Fluoroquinolone antibacterial agents have been reported to induce tendon lesions in juvenile rats. In the present study, we characterized fluoroquinolone-induced Achilles tendon lesions by comparing the effects of 10 fluoroquinolones and examining the potential of one of these antimicrobial agents, pefloxacin, to induce tendon lesions when coadministered with one of nine anti-inflammatory compounds. Among the 10 fluoroquinolones tested, fleroxacin and pefloxacin were the most toxic, inducing lesions at a dose of 100 mg/kg of body weight or more, while lomefloxacin, levofloxacin, and ofloxacin or sparfloxacin and enoxacin induced lesions at 300 mg/kg or more and 900 mg/kg, respectively. In contrast, norfloxacin, ciprofloxacin, and tosufloxacin had no effect even at the high dose of 900 mg/kg. The severity of the Achilles tendon lesions appeared to correlate with the structure of the substituent at the seventh position. Furthermore, pefloxacin-induced tendon lesions were inhibited by coadministration with dexamethasone and N-nitro-L-arginine methyl ester. Phenidone (1-phenyl-3-pyrazolidinone) and 2-(12-hydroxydodeca-5,10-diynyl)3,5,6-trimethyl-1,4-benzoqui none (AA861) also decreased the incidence of tendon lesions. In contrast, catalase, dimethyl sulfoxide, indomethacin, pyrilamine, and cimetidine did not modify these tendon lesions. These results suggest that nitric oxide and 5-lipoxigenase products partly mediate fluoroquinolone-induced tendon lesions.

Citing Articles

Fluoroquinolone-Mediated Tendinopathy and Tendon Rupture.

Duman E, Muller-Deubert S, Pattappa G, Stratos I, Sieber S, Clausen-Schaumann H Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005998 PMC: 11858458. DOI: 10.3390/ph18020184.


The fluoroquinolones may positively affect tendon healing after surgical repair.

Demir T, Sener E, Ozturk A, Bekmezci T, Esen E, Kaplanoglu G Jt Dis Relat Surg. 2024; 35(3):654-661.

PMID: 39189576 PMC: 11411887. DOI: 10.52312/jdrs.2024.1832.


Short-Term Exposure to Ciprofloxacin Reduces Proteoglycan Loss in Tendon Explants.

James S, Daffy J, Cook J, Samiric T Genes (Basel). 2022; 13(12).

PMID: 36553476 PMC: 9777606. DOI: 10.3390/genes13122210.


Novel Bacterial Topoisomerase Inhibitor Gepotidacin Demonstrates Absence of Fluoroquinolone-Like Arthropathy in Juvenile Rats.

Fishman C, Caverly Rae J, Posobiec L, Laffan S, Lerman S, Pearson N Antimicrob Agents Chemother. 2022; 66(11):e0048322.

PMID: 36255258 PMC: 9664842. DOI: 10.1128/aac.00483-22.


Association Between Third-Generation Fluoroquinolones and Achilles Tendon Rupture: A Self-Controlled Case Series Analysis.

Chinen T, Sasabuchi Y, Matsui H, Yasunaga H Ann Fam Med. 2021; 19(3):212-216.

PMID: 34180840 PMC: 8118488. DOI: 10.1370/afm.2673.


References
1.
Higgs G, Moncada S, Vane J . Eicosanoids in inflammation. Ann Clin Res. 1984; 16(5-6):287-99. View

2.
Black K, Hoff J . Leukotrienes increase blood-brain barrier permeability following intraparenchymal injections in rats. Ann Neurol. 1985; 18(3):349-51. DOI: 10.1002/ana.410180313. View

3.
McEwan S, Davey P . Ciprofloxacin and tenosynovitis. Lancet. 1988; 2(8616):900. DOI: 10.1016/s0140-6736(88)92489-0. View

4.
Hibbs Jr J, Taintor R, Vavrin Z, Rachlin E . Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988; 157(1):87-94. DOI: 10.1016/s0006-291x(88)80015-9. View

5.
Curran R, Billiar T, Stuehr D, Hofmann K, Simmons R . Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med. 1989; 170(5):1769-74. PMC: 2189496. DOI: 10.1084/jem.170.5.1769. View